• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

疫苗免疫全球联盟(Gavi)关于人乳头瘤病毒(HPV)疫苗接种的声明:供应限制不再存在——迈向实现世界卫生组织(WHO)的疫苗目标

IPVS STATEMENT on HPV vaccination: No longer supply constraints: Towards achieving WHO vaccine targets.

作者信息

Garland Suzanne M, Bhatla Neerja, Woo Yin Ling

机构信息

Reproductive & Neonatal Infectious Diseases, Department of Obstetrics and Gynaecology, University of Melbourne, Director Centre Women's Infectious Diseases Research, Honorary Research Fellow, Infection & Immunity, Murdoch Children's Research Institute, Parkville, VIC 3052, Australia.

Department of Obstetrics & Gynaecology, Room 3101, Teaching Block, All India Institute of Medical Sciences, New Delhi 110029, India.

出版信息

Vaccine. 2024 Dec 2;42(26):126400. doi: 10.1016/j.vaccine.2024.126400. Epub 2024 Oct 2.

DOI:10.1016/j.vaccine.2024.126400
PMID:39366196
Abstract

The global supply of human papillomavirus (HPV) prophylactic vaccines has been constrained since 2020.Vaccine manufacturers have increased capacity and new HPV vaccines are now available. Vaccine supply is now able to meet the full HPV vaccine demand which has been achieved earlier than predicted.

摘要

自2020年以来,全球人乳头瘤病毒(HPV)预防性疫苗的供应一直受到限制。疫苗制造商已提高产能,现在有了新的HPV疫苗。目前疫苗供应能够满足全部HPV疫苗需求,这一目标的实现比预期更早。

相似文献

1
IPVS STATEMENT on HPV vaccination: No longer supply constraints: Towards achieving WHO vaccine targets.疫苗免疫全球联盟(Gavi)关于人乳头瘤病毒(HPV)疫苗接种的声明:供应限制不再存在——迈向实现世界卫生组织(WHO)的疫苗目标
Vaccine. 2024 Dec 2;42(26):126400. doi: 10.1016/j.vaccine.2024.126400. Epub 2024 Oct 2.
2
Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors.接种人乳头瘤病毒预防性疫苗以预防宫颈癌及其癌前病变。
Cochrane Database Syst Rev. 2018 May 9;5(5):CD009069. doi: 10.1002/14651858.CD009069.pub3.
3
Investigating factors affecting the effectiveness of Gardasil 4, Cervarix, and Gardasil 9 vaccines considering the WHO regions in females: A systematic review.考虑世界卫生组织各区域因素,调查加德西4价、卉妍康和加德西9价疫苗在女性中的有效性:一项系统评价。
Cancer Epidemiol. 2025 Apr;95:102759. doi: 10.1016/j.canep.2025.102759. Epub 2025 Feb 5.
4
Drivers of human papillomavirus vaccine uptake in migrant populations and interventions to improve coverage: a systematic review and meta-analysis.移民人群中人类乳头瘤病毒疫苗接种的驱动因素及提高覆盖率的干预措施:一项系统评价和荟萃分析
Lancet Public Health. 2025 Aug;10(8):e693-e711. doi: 10.1016/S2468-2667(25)00148-3.
5
Knowledge and awareness of HPV vaccine and acceptability to vaccinate in sub-Saharan Africa: a systematic review.撒哈拉以南非洲地区对人乳头瘤病毒(HPV)疫苗的认知、了解程度及接种意愿:一项系统综述
PLoS One. 2014 Mar 11;9(3):e90912. doi: 10.1371/journal.pone.0090912. eCollection 2014.
6
Inconclusive evidence for non-inferior immunogenicity of two- compared with three-dose HPV immunization schedules in preadolescent girls: A systematic review and meta-analysis.关于在青春期前女孩中,两剂与三剂 HPV 免疫接种方案相比免疫原性非劣效性的不确定证据:系统评价和荟萃分析。
J Infect. 2015 Jul;71(1):61-73. doi: 10.1016/j.jinf.2015.02.005. Epub 2015 Feb 21.
7
Population-level impact and herd effects following human papillomavirus vaccination programmes: a systematic review and meta-analysis.人乳头瘤病毒疫苗接种计划后的人群水平影响及群体效应:一项系统评价和荟萃分析。
Lancet Infect Dis. 2015 May;15(5):565-80. doi: 10.1016/S1473-3099(14)71073-4. Epub 2015 Mar 3.
8
Meeting report: Considerations for trial design and endpoints in licensing therapeutic HPV16/18 vaccines to prevent cervical cancer.会议报告:在许可治疗性 HPV16/18 疫苗预防宫颈癌的临床试验设计和终点方面的考虑因素。
Vaccine. 2024 Nov 14;42(25):126100. doi: 10.1016/j.vaccine.2024.07.001. Epub 2024 Jul 14.
9
Barriers and strategies to enhance HPV vaccine uptake in adolescents living with HIV and their guardians in Lilongwe, Malawi.在马拉维利隆圭,提高感染艾滋病毒青少年及其监护人对人乳头瘤病毒(HPV)疫苗接种率的障碍与策略。
Sci Rep. 2025 Sep 1;15(1):32230. doi: 10.1038/s41598-025-03145-x.
10
Influence of Pre-Vaccination HPV Status on Vaccine Effectiveness Among Chinese Women: A Multicenter Cross-Sectional Study.接种疫苗前HPV状态对中国女性疫苗效力的影响:一项多中心横断面研究
Cancer Rep (Hoboken). 2025 Sep;8(9):e70294. doi: 10.1002/cnr2.70294.

引用本文的文献

1
Cost-effectiveness of self-sampling and enhanced strategies for HPV prevention among men who have sex with men in China: a modeling study.中国男男性行为者中HPV预防的自我采样及强化策略的成本效益:一项建模研究
BMC Med. 2025 Jul 1;23(1):362. doi: 10.1186/s12916-025-04131-w.